Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 8/20 | 0.55 |
| ▸ | MME | P08473 | 7/20 | 0.55 |
| ▸ | CPA1 | P15085 | 6/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 6/20 | 0.55 |
| ▸ | CTSD | P07339 | 5/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29378009 | 0.98 | CTSD (0.58) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL29350276 | 0.93 | ACE (0.57) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL29608723 | 0.93 | CTSD (0.51) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL30052882 | 0.92 | CTSD (0.58) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL30056652 | 0.90 | MME (0.60) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL29876711 | 0.89 | ACE (0.58) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL30051904 | 0.88 | MME (0.57) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL30051990 | 0.87 | CTSD (0.61) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL15649661 | 0.87 | ACE (0.61) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL30735528 | 0.86 | MME (0.57) | ACEMMECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220363759-A1 | ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN 3 (TIM-3) | ANAPTYSBIO, INC. | 2022-11-17 | — | — | US | claimed |
| EP-4594335-A1 | COMPOUND - DIAGNOSTIC MARKER FOR OVARIAN CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF OVARIAN CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF OVARIAN CANCER | Urteste S.A. (PL) | 2025-08-06 | — | — | EP | disclosed |
| CN-119998307-A | Compound-ovarian cancer diagnostic markers, method for detecting enzymatic activity, method for diagnosing ovarian cancer, kit comprising said compound, use of said compound and method for treating ovarian cancer | 尔特斯特公司 | 2025-05-13 | — | — | CN | disclosed |
| EP-4442712-A2 | ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN 3 (TIM-3) | AnaptysBio, Inc. (US) | 2024-10-09 | — | — | EP | disclosed |
| CN-114539409-B | Antibodies to T cell immunoglobulin and mucin 3 (TIM-3) | 安奈普泰斯生物有限公司 | 2024-09-17 | — | — | CN | disclosed |
| WO-2024072241-A1 | COMPOUND - DIAGNOSTIC MARKER FOR OVARIAN CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF OVARIAN CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF OVARIAN CANCER | URTESTE S.A. (PL) | 2024-04-04 | — | — | WO | disclosed |
| US-20220363759-A1 | ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN 3 (TIM-3) | ANAPTYSBIO, INC. | 2022-11-17 | — | — | US | disclosed |
| US-11352427-B2 | Antibodies directed against T Cell immunoglobulin and mucin protein 3 (TIM-3) | ANAPTYSBIO, INC. (US) | 2022-06-07 | — | — | US | disclosed |
| CN-114539409-A | Antibodies against T cell immunoglobulin and mucin protein 3(TIM-3) | 安奈普泰斯生物有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-107847589-B | Antibodies against T cell immunoglobulin and mucin protein 3(TIM-3) | 安奈普泰斯生物有限公司 | 2022-03-29 | — | — | CN | disclosed |